Mosanna Therapeutics Reports Positive Results from the Phase 1 MOSAIC Study of MOS118 for Obstructive Sleep Apnea

Posted on by sHq_LoGiNz

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Mosanna Therapeutics Reports Positive Results from the Phase 1 MOSAIC Study of MOS118 for Obstructive Sleep Apnea

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.